Expression of proliferating cell nuclear antigen and CD44 variant exon 6 in primary tumors and corresponding lymph node metastases of colorectal carcinoma with Duke's stage C or D

World Journal of Gastroenterology

Volumn 9, Issue 7, 2003, Pages 1482-1486

  Zhang, Ji Cheng ^a   Wang, Zuo Ren ^a   Cheng, Yan Juan ^b   Yang, Ding Zhong ^a   Shi, Jing Sen ^a   Liang, Ai Lin ^b   Liu, Ning Na ^b   Wang, Xiao Min ^b  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b Shaanxi Cancer Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD44V6 ANTIGEN; CYCLINE; FORMALDEHYDE; PARAFFIN;

ADENOCARCINOMA; ADULT; ARTICLE; CANCER CELL; CANCER STAGING; CELL PROLIFERATION; COLORECTAL CARCINOMA; CORRELATION ANALYSIS; EXON; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MUCINOUS CARCINOMA; PAPILLARY CARCINOMA; PROTEIN EXPRESSION; SIGNET RING CARCINOMA; STAINING; STATISTICAL ANALYSIS; TISSUE FIXATION; TISSUE PREPARATION; UNDIFFERENTIATED CARCINOMA;

EID: 0042565832     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i7.1482     Document Type: Article

References (37)

1. Mayer RJ, O'Connell MJ, Tepper JE, Wolmark N. Status of adjuvant therapy for colorectal cancer. J Natl Cancer Inst 1989; 81: 1359-1364
2. Moertel CG. Chemotherapy for colorectal cancer. N Engl J Med 1994; 330: 1135-1142
3. Steele G Jr. Advances in the treatment of early- to late-stage colorectal cancer: 20 years of progress. Ann Surg Oncol 1995; 2: 77-88
4. Greene FL, Stewart AK, Norton HJ. A new TNM staging strategy for node-positive (stage III) colon cancer: An analysis of 50, 042 patients. Ann Surg 2002; 236: 416-421
5. Fisher ER, Sass R, Palekar A, Fisher B, Wolmark N. Dukes' classification revisited. Findings from the National Surgical Adjuvant Breast and Bowel Projects (Protocol R-01). Cancer 1989; 64: 2354-2360
6. Douglass HO Jr, Moertel CG, Mayer RJ, Thomas PR, Lindblad AS, Mittleman A, Stablein DM, Bruckner HW. Survival after postoperative combination treatment of rectal cancer. N Engl J Med 1986; 315: 1294-1295
7. Laurie JA, Moertel CG, Fleming TR, Wieand HS, Leigh JE, Rubin J, McCormack GW, Gerstner JB, Krook JE, Malliard J. Surgical adjuvant therapy of large-bowel carcinoma: An evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic. J Clin Oncol 1989; 7: 1447-1456
8. Krook JE, Moertel CG, Gunderson LL, Wieand HS, Collins RT, Beart RW, Kubista TP, Poon MA, Meyers WC, Mailliard JA. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991; 324: 709-715
9. Harris GJ, Church JM, Senagore AJ, Lavery IC, Hull TL, Strong SA, Fazio VW. Factors affecting local recurrence of colonic adenocarcinoma. Dis Colon Rectum 2002; 45: 1029-1034
10. Kanazawa Y, Onda M, Tanaka N, Seya T. Proliferating cell nuclear antigen and p53 protein expression in submucosal invasive colorectal carcinoma. J Nippon Med Sch 2000; 67: 242-249
11. Onodera H, Maetani S, Kawamoto K, Kan S, Kondo S, Imamura M. Pathologic significance of tumor progression in locally recurrent rectal cancer: Different nature from primary cancer. Dis Colon Rectum 2000; 43: 775-781
12. Seong J, Chung EJ, Kim H, Kim GE, Kim NK, Sohn SK, Min JS, Suh CO. Assessment of biomarkers in paired primary and recurrent colorectal adenocarcinomas. Int J Radiat Oncol Biol Phys 1999; 45: 1167-1173
13. Wielenga VJ, Heider KH, Offerhaus GJ, Adolf GR, Van Den Berg FM, Ponta H, Herrlich P, Pals ST. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 1993; 53: 4754-4756
14. Finn L, Dougherty G, Finley G, Meisler A, Becich M, Cooper DL. Alternative splicing of CD44 pre-mRNA in human colorectal tumors. Biochem Biophys Res Commun 1994; 200: 1015-1022
15. Fox SB, Fawcett J, Jackson DG, Collins I, Gatter KC, Harris AL, Gearing A, Simmons DL. Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms. Cancer Res 1994; 54: 4539-4546
16. Mulder JW, Kruyt PM, Sewnath M, Oosting J, Seldenrijk CA, Weidema WF, Offerhaus GJ, Pals ST. Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet 1994; 344: 1470-1472
17. Gotley DC, Fawcett J, Walsh MD, Reeder JA, Simmons DL, Antalis TM. Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer. Br J Cancer 1996; 74: 342-351
18. Fukuse T, Hirata T, Tanaka F, Yanagihara K, Hitomi S, Wada H. Prognosis of ipsilateral intrapulmonary metastases in resected nonsmall cell lung cancer. Eur J Cardiothorac Surg 1997; 12: 218-223
19. Ichinose Y, Hara N, Ohta M. Synchronous lung cancers defined by deoxyribonucleic acid flow cytometry. J Thorac Cardiovasc Surg 1991; 102: 418-424
20. Martini N, Melamed MR. Multiple primary lung cancers. J Thorac Cardiovasc Surg 1975; 70: 606-612
21. Nanashima A, Yamaguchi H, Sawai T, Yasutake T, Tsuji T, Jibiki M, Yamaguchi E, Nakagoe T, Ayabe H. Expression of adhesion molecules in hepatic metastases of colorectal carcinoma: Relationship to primary tumours and prognosis after hepatic resection. J Gastroenterol Hepatol 1999; 14: 1004-1009
22. Bravo R, Frank R, Blundell PA, Macdonald-Bravo H. Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature 1987; 326: 515-517
23. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990; 61: 1303-1313
24. Gunthert U, Hofmann M, Rudy W, Reber S, Zoller M, Haussmann I, Matzku S, Wenzel A, Ponta H, Herrlich P. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991; 65: 13-24
25. Kimball PM, Brattain MG. Isolation of a cellular subpopulation from a human colonic carcinoma cell line. Cancer Res 1980; 40: 1574-1579
26. Brattain MG, Fine WD, Khaled FM, Thompson J, Brattain DE. Heterogeneity of malignant cells from a human colonic carcinoma. Cancer Res 1981; 41: 1751-1756
27. Fidler IJ. Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res 1978; 38: 2651-2660
28. Fidler IJ. Critical factors in the biology of human cancer metastasis: Twenty-eighth G.H.A. Clowes memorial award lecture. Cancer Res 1990; 50: 6130-6138
29. Dexter DL, Spremulli EN, Fligiel Z, Barbosa JA, Vogel R, Van Voorhees A, Calabresi P. Heterogeneity of cancer cells from a single human colon carcinoma. Am J Med 1981; 71: 949-956
30. Dexter DL, Kowalski HM, Blazar BA, Fligiel Z, Vogel R, Heppner GH. Heterogeneity of tumor cells from a single mouse mammary tumor. Cancer Res 1978; 38: 3174-3181
31. Bonsing BA, Corver WE, Fleuren GJ, Cleton-Jansen AM, Devilee P, Cornelisse CJ. Allelotype analysis of flow-sorted breast cancer cells demonstrates genetically related diploid and aneuploid subpopulations in primary tumors and lymph node metastases. Genes Chromosomes Cancer 2000; 28: 173-183
32. Solimene AC, Carneiro CR, Melati I, Lopes JD. Functional differences between two morphologically distinct cell subpopulations within a human colorectal carcinoma cell line. Braz J Med Biol Res 2001; 34: 653-661
33. Yasoshima T, Denno R, Kawaguchi S, Sato N, Okada Y, Ura H, Kikuchi K, Hirata K. Establishment and characterization of human gastric carcinoma lines with high metastatic potential in the liver: Changes in integrin expression associated with the ability to metastasize in the liver of nude mice. Jpn J Cancer Res 1996; 87: 153-160
34. Samiei M, Waghorne CG. Clonal selection within metastatic SP1 mouse mammary tumors is independent of metastatic potential. Int J Cancer 1991; 47: 771-775
35. Li Y, Tang ZY, Ye SL, Liu YK, Chen J, Xue Q, Chen J, Gao DM, Bao WH. Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97. World J Gastroenterol 2001; 7: 630-636
36. Price JE, Bell C, Frost P. The use of a genotypic marker to demonstrate clonal dominance during the growth and metastasis of a human breast carcinoma in nude mice. Int J Cancer 1990; 45: 968-971
37. Suzuki N, Frapart M, Grdina DJ, Meistrich ML, Withers HR. Cell cycle dependency of metastatic lung colony formation. Cancer Res 1977; 37: 3690-3693